Alprazolam Tablet
FDA Recall NDC 59762-3721

FDA Enforcement Report: View Recall Date, Reasons, and Safety Status

Active & Historical Enforcement Reports

The FDA has identified 1 recorded enforcement report(s) associated with Alprazolam (NDC 59762-3721). A significant event, classified as Class II, was initiated on Dec 17, 2014 by Mylan Pharmaceuticals Inc.. The reported reason for this action was: "Subpotent Drug"

This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.

Reported Recall Events

December 2014 Class II Recall: Subpotent Drug

Recall Number
Class II Terminated
Reason for Recall
Subpotent Drug
Initiated
Dec 17, 2014
Reported
Dec 31, 2014
Quantity
12,310 bottles

Recall Profile & Regulatory Data

Event ID
69985
Classification
Class II
Enforcement Status
Terminated
Recalling Firm
Neolpharma, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide
Termination Date
Apr 26, 2017
Product Description
Alprazolam tablets, USP, CIV, 0.25 mg, Rx Only, a) 500 count bottle, b) 1000 count bottle, Distributed by: Greenstone LLC, Peapack, NJ, 07977, a) NDC 59762-3719-3, b) NDC 59762-3719-4.
Batch or Lot Expiration Information
Lot# : a) C100429, Exp 03/15, b) C120293, Exp 01/17
Affected Packages Involved in this Recall
59762-3719-1Product
59762-3719-3Product
59762-3719-4Product
59762-3720-1Product
59762-3720-3Product
59762-3720-4Product
59762-3721-1Product
59762-3721-3Product
59762-3721-4Product
59762-3722-1Product
59762-3722-3Product

About FDA Recall Enforcement Reports

FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.

If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.